Stryker Corporation, commonly referred to as Stryker, is a leading global medical technology company headquartered in the United States. Founded in 1941, Stryker has established itself as a key player in the orthopaedics, surgical equipment, and neurotechnology sectors, with significant operations across North America, Europe, and Asia-Pacific. The company is renowned for its innovative products, including advanced surgical instruments, implantable devices, and patient handling solutions, which are designed to enhance surgical outcomes and improve patient care. Stryker's commitment to quality and innovation has positioned it as a trusted partner in the healthcare industry, earning numerous accolades for its contributions to medical technology. With a strong market presence, Stryker continues to lead the way in developing cutting-edge solutions that address the evolving needs of healthcare professionals and patients alike.
How does Stryker's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Stryker's score of 36 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Stryker Corporation reported total emissions of approximately 54,854,000 kg CO2e for Scope 1 and about 81,619,000 kg CO2e for Scope 2, reflecting their commitment to reducing carbon emissions. The company has set an ambitious target to achieve a 20% reduction in Scope 1 and 2 emissions by 2024, using a 2019 baseline. This goal is part of their broader commitment to carbon neutrality for these scopes by 2030. In 2022, Stryker's total emissions were approximately 243,317,000 kg CO2e, with Scope 1 emissions at about 57,383,000 kg CO2e, Scope 2 emissions at approximately 117,059,000 kg CO2e, and Scope 3 emissions from business travel estimated at 68,875,000 kg CO2e. The company has disclosed emissions data for Scopes 1, 2, and 3, demonstrating transparency in their environmental impact. Stryker's climate commitments are structured around their goal of making their facilities carbon neutral for Scopes 1 and 2 by 2030. This initiative is part of their long-term strategy to operate sustainably and improve healthcare outcomes. The company is currently on track to meet its interim reduction targets, reinforcing its dedication to environmental stewardship within the healthcare equipment and supplies sector.
Access structured emissions data, company-specific emission factors, and source documents
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Scope 1 | - | 00,000,000 | - | - | 00,000,000 |
Scope 2 | 146,705,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
Scope 3 | - | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Stryker is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.